EBMT NEWSLETTER | May 2017 | EBMT 2017 Post Congress Bulletin

Important dates

9th Meeting of the Quality Management Group
EBMT 2018
Draft 7th edition, FACT-JACIE Standards
JACIE in Spain

9th Meeting of the Quality Management Group

A packed room was testimony to the high interest in the quality management content in Marseille. Speakers presented on the draft 7th edition of the FACT-JACIE Standards, a basic introduction to accreditation, an open Inspectors Session and a series of real-life cases on Corrective-and-Preventive-Actions and Outcome Assessment that kept the audience stimulated all day. A rough count showed 90 attendees from almost 30 countries of which approximately 40% were inspectors.

Aside from the room proving too small (and too warm!) for all of the interested attendees at the start of the day, the quality and variety of the presentations proved very interesting and will likely be the basis of the format for Lisbon in 2018 (with a bigger room!)

Figure 1 Dr. Kim Orchard presenting the draft 7th edition of the FACT-JACIE Standards

JACIE was also present as part of the Nurses Group programme with a well-received presentation entitled “JACIE 7th ed. standards: What are the changes for a HSCT coordinator nurse?” generating interesting discussion, not least of all about whether the important role of the Coordinator can be better reflected in the Standards in the future.

The EBMT is committed to recognising JACIE Inspectors and we are planning more initiatives in the future. The invaluable work and effort of the JACIE Inspectors were acknowledged during the Opening Session with a mosaic of inspectors’ photographs forming on the giant screen as Prof. Christian Chabannon, Congress President and JACIE Inspector, highlighted why the inspectors’ role is so critical to driving continuous improvement in transplantation centres and processes. More information on this or on any aspect of being an inspector from Áurea Villar, HR (Volunteers) Coordinator, at inspectors@ebmt.org.

As always, the JACIE Team enjoyed the chance to see and talk to old friends and make new ones from all over the world. These encounters keep our feet on the ground and are our favourite way to know what is happening at the front line of quality and transplantation.

Finally, thank you to all our speakers and chairs who make the meeting possible. We are truly honoured to have you with us and sharing your expertise and knowledge.



ISCT Annual Meeting, London, 3-6 May 2017 (exhibitors)
GATMO/LABMT Congress, Buenos Aires, 17 May 2017 (FACT-JACIE workshop)
JACIE Training Course, Barcelona, 1-2 June (course primarily for future inspectors)

More information from jacie@ebmt.org and www.jacie.org

EBMT 2018

20th anniversary of JACIE

For Lisbon 2018, we are already thinking about the programme and would be very happy to hear from readers with their ideas for subjects or formats. 2018 will also be the 20th anniversary of the establishment of JACIE so expect some special events to mark this achievement.

Also, keep in mind that we are very keen to see original research included in the Quality Management programme next year and so strongly urge you to think about practice in your centre, audits that you performed and associated corrective actions that would be of interest to a wider audience. We have seen centres in different countries grapple with almost identical challenges and therefore your experience will very probably resonate with colleagues in other transplant programmes. So have a think and watch out for the Abstracts announcement after the summer. 

Draft 7th edition, FACT-JACIE Standards - Public consultation 

The Foundation for the Accreditation of Cellular Therapy (FACT) and the Joint Accreditation Committee of ISCT-EBMT (JACIE) have published the draft 7th edition of the FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration for inspection and public comment for a 90-day period. Comments will be accepted from May 1, 2017 through July 30, 2017.
These Standards apply to all phases of collection, processing, storage, and administration of hematopoietic cellular therapy products. This includes hematopoietic progenitor cells (HPCs), mononuclear cells (MNCs), and immune effector cells (IECs) derived from marrow, apheresis, or cord blood, and administered by a FACT-accredited blood and marrow transplant team.
Description and Instructions for FACT-JACIE Standards
Draft FACT-JACIE Standards
Draft FACT-JACIE Manual
To submit comments regarding the draft 7th edition FACT-JACIE Standards, follow the steps below. Comments will be accepted through July 30, 2017.
  1. Access the Comment Form at https://www.surveymonkey.com/r/FACT-JACIE.
  2. Type in your contact information and comments on the form. Fill in all fields so that the Standards Committee fully understands your position.
  3. Submit the form when you are finished. Once the form has been submitted, it cannot be changed. However, additional comments may be submitted by completing the form again. There is no limit to the number of forms that can be submitted.

JACIE in Spain

Following on from the agreement signed in late-2016 by EBMT, Fundación CAT and the National Transplant Organisation (ONT in Spanish), an information day was held in Madrid on 20 April. In a format that facilitated easy discussion and exchange of experience, participants learned about the Standards, the accreditation process and the additional requirements established by Fundación CAT. This collaboration will allow Spanish transplant programmes to achieve two certificates in a single process with the endorsement of the ONT to those centres that are successful. The very positive response to the event has led to consideration of repeating it again later in 2017 to allow more centres to participate. More information from Iris Bargalló, Accreditations Coordinator at iris.bargallo@ebmt.org.

Figure 2 Participants at the CAT-JACIE Information Day in Madrid
Bookmark and Share